首页|氯替泼诺联合人工泪液对白内障术后干眼症患者Toll样受体-核因子κB信号通路相关因子的影响

氯替泼诺联合人工泪液对白内障术后干眼症患者Toll样受体-核因子κB信号通路相关因子的影响

扫码查看
目的 分析氯替泼诺联合人工泪液对白内障术后干眼症患者Toll样受体(TLR)-核因子κ B(NF-κB)信号通路相关因子的影响。方法 回顾性分析2020年12月至2023年12月赣州启明星眼科医院收治的110例白内障术后干眼症患者的临床资料,根据治疗方法的不同分为对照组(n=55)与试验组(n=55)。对照组给予人工泪液治疗,试验组给予氯替泼诺联合人工泪液治疗,比较两组患者的治疗总有效率、角膜荧光素染色(FL)评分、美国国家眼科研究所视觉相关生命质量量表(NEI-VFQ-25)评分、泪液肿瘤坏死因子-α(TNF-α)、白细胞介素-1 β(IL-1 β)水平及血清TLR4、NF-κB水平。结果 对照组、试验组患者治疗总有效率分别为74。55%、90。91%,试验组的治疗总有效率高于对照组,差异有统计学意义(P<0。05)。治疗后,两组患者的FL评分均低于同组治疗前,且试验组的FL评分低于对照组,差异有统计学意义(P<0。05)。治疗后,两组患者的TNF-α、IL-1 β水平均低于同组治疗前,且试验组的TNF-α、IL-1β水平均低于对照组,差异有统计学意义(P<0。05)。治疗后,两组患者的TLR4、NF-κB水平均低于同组治疗前,且试验组的TLR4、NF-κB水平均低于对照组,差异有统计学意义(P<0。05)。治疗后,两组患者的生活质量各项评分均高于同组治疗前,且试验组的生活质量各项评分均高于对照组,差异有统计学意义(P<0。05)。结论 氯替泼诺联合人工泪液治疗白内障术后干眼症患者效果较好,可有效提高泪膜稳定性,可提高患者生活质量,与氯替泼诺联合人工泪液治疗通过介导TLR-NF-κ B信号通路降低眼表炎症状态有关,可推广应用。
Effect of Cloteprednol combined with artificial tears on factors related to Toll like receptor-nuclear factor κB signaling pathway in patients with dry eye after cataract surgery
Objective To analyze the effect of Cloteprednol combined with artificial tears on factors related to Toll like re-ceptor(TLR)-nuclear factor κB(NF-κB)signaling pathway in patients with dry eye after cataract surgery.Methods The clinical data of 110 patients with dry eye syndrome after cataract surgery admitted to Ganzhou Qi Ming Xing Ophthalmic Hospital from December 2020 to December 2023 were retrospectively analyzed.According to the different treatment meth-ods,they were divided into control group(n=55)and experimental group(n=55).The control group was treated with artificial tears,and the experimental group was treated with Cloteprednol combined with artificial tears.The total effective rate,corneal fluorescein staining(FL)score,National Eye Institute visual function questionnaire(NEI-VFQ-25)score,tear tumor necrosis factor-α(TNF-α)and interleukin-1 β(IL-1 β)levels,and serum TLR4 and NF-κB levels were compared be-tween the two groups.Results The total effective rate of the control group and the experimental group was 74.55%and 90.91%,respectively.The total effective rate of the experimental group was higher than that of the control group,and the difference was statistically significant(P<0.05).After treatment,the FL scores in two groups were lower than those before treatment,and the FL score in the experimental group was lower than that in the control group,and the differences were sta-tistically significant(P<0.05).After treatment,the levels of TNF-α and IL-1β in the two groups were lower than those before treatment,and the levels of TNF-α and IL-1 β in the experimental group were lower than those in the control group,and the differences were statistically significant(P<0.05).After treatment,the levels of TLR4 and NF-κB in the two groups were lower than those before treatment,and the levels of TLR4 and NF-κB in the experimental group were lower than those in the control group,and the differences were statistically significant(P<0.05).After treatment,the scores of quality of life in the two groups were higher than those before treatment,and the scores of quality of life in the experimental group were higher than those in the control group,and the differences were statistically significant(P<0.05).Conclusion Cloteprednol combined with artificial tears can effectively improve the stability of tear film and improve the quality of life of patients with dry eye after cataract surgery,which is related to the treatment of Cloteprednol combined with artificial tears by mediating TLR-NF-κB signaling pathway to reduce ocular surface inflammation,and can be widely used.

CloteprednolArtificial tearsCataractDry eyeToll like receptor-nuclear factor κB signaling pathway

许慕岚、李恩钦

展开 >

江西省赣州启明星眼科医院眼科,江西赣州 341000

氯替泼诺 人工泪液 白内障 干眼症 Toll样受体-核因子κB信号通路

江西省中医药管理局计划项目

2021B0919

2024

中国当代医药
中国保健协会 当代创新(北京)医药科学研究院

中国当代医药

影响因子:1.215
ISSN:1674-4721
年,卷(期):2024.31(21)